C12N 2770/32361
Methods of inactivation or attenuation
C12N2770/32361 (Methods of inactivation or attenuation) appears on 21 US grants and 23 published applications in this corpus.
Search patents in C12N- Granted patents
- 21
- Published applications
- 23
- Assignees
- 22
- Inventors
- 70
- Latest grant
- 6 May 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1994 | 1 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 2 | 0 |
| 2001 | 1 | 0 |
| 2002 | 1 | 1 |
| 2003 | 1 | 2 |
| 2004 | 0 | 1 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 2 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 1 |
| 2010 | 1 | 1 |
| 2011 | 1 | 1 |
| 2012 | 0 | 2 |
| 2013 | 0 | 0 |
| 2014 | 2 | 1 |
| 2015 | 1 | 0 |
| 2016 | 0 | 2 |
| 2017 | 2 | 1 |
| 2018 | 0 | 4 |
| 2019 | 3 | 1 |
| 2020 | 1 | 1 |
| 2021 | 0 | 0 |
| 2022 | 1 | 1 |
| 2023 | 0 | 0 |
| 2024 | 0 | 1 |
| 2025 | 1 | 1 |
| 2026 | 0 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Adapted enterovirus D68 that propagates to high titer in vero cells6 May 2025US 12,290,555 B2Bharat Biotech International Limited
- Stable production of virulent enterovirus 71 and use thereof24 May 2022US 11,339,376 B2Tokyo Metropolitan Institute of Medical Science
- Hand, foot, and mouth vaccines and methods of manufacture and use thereof20 Oct 2020US 10,806,782 B2Takeda Vaccines, Inc.
- Cationic polyamines for treatment of viruses26 Nov 2019US 10,485,824 B2Agency for Science, Technology and Research
- Hand, foot, and mouth vaccines and methods of manufacture and use thereof19 Mar 2019US 10,233,429 B2Takeda Vaccines, Inc.
- Bivalent inactivated ev71-ca16 vaccine, method for preparing the same, and use thereof12 Mar 2026US 2026/0069673 A1Aim Action Biopharm Co., Ltd
- Coxsackievirus B Compositions and Methods Of Use Thereof20 Nov 2025US 2025/0352634 A1Vactech Oy
- Encapsulated rna polynucleotides and methods of use11 Apr 2024US 2024/0115636 A1ElevateBio Technologies, Inc.
- Adaptation of enterovirus to vero cells and vaccine formulations thereof26 May 2022US 2022/0160862 A1Bharat Biotech International Limited
- Stable production of virulent enterovirus 71 and use thereof30 Jan 2020US 2020/0032222 A1Tokyo Metropolitan Institute of Medical Science
Most cited
By later US patents
- Methods and compositions for the selective modification of nucleic acids24US 6,093,564 AV. I. Technologies, Inc. · 2000
- Coxsackie virus as a vector for delivery of anti-inflammatory cytokines16US 6,071,742 ABoard of Regents of the University of Nebraska · 2000
- Coxsackie virus vectors for delivery of nucleic acids encoding antigenic or therapeutic products6US 6,323,024 B1Board of Regents of the University of Nebraska · 2001
- IPV-DPT vaccine6US 8,753,646 B2Japan Poliomyelitis Research Institute · 2014
- Methods and compositions for the selective modification of nucleic acids5US 6,352,695 B1V. I. Technologies, Inc. · 2002